|
Volumn 13, Issue 3, 2010, Pages 177-180
|
Efficacy and safety evaluation of docetaxel plus oxaliplatin and capecitabine in the treatment of advanced gastric adenocarcinoma: a single center non-controlled phase II clinical trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAPECITABINE;
DEOXYCYTIDINE;
DOCETAXEL;
DRUG DERIVATIVE;
FLUOROURACIL;
OXALIPLATIN;
PLATINUM COMPLEX;
TAXOID;
ADENOCARCINOMA;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
PHASE 2 CLINICAL TRIAL;
STOMACH TUMOR;
TREATMENT OUTCOME;
ADENOCARCINOMA;
ADOLESCENT;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DEOXYCYTIDINE;
FEMALE;
FLUOROURACIL;
HUMANS;
MALE;
MIDDLE AGED;
ORGANOPLATINUM COMPOUNDS;
STOMACH NEOPLASMS;
TAXOIDS;
TREATMENT OUTCOME;
YOUNG ADULT;
|
EID: 77953154407
PISSN: 16710274
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|